Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

NCT03818503 is registered in ClinicalTrials.gov with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor.

NCT NCT03818503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03818503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
Lead sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Phase
Observational
Overall status
Recruiting
Start date
June 24, 2019
Completion date
April 30, 2026
Enrollment
2,000 (estimated)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

cancer